MYOTEST NERVE STIMULATOR— 510(k) K823583

Substantially Equivalent

Prothia USA, Inc.

FDA 510(k) clearance K823583 for MYOTEST NERVE STIMULATOR, Substantially Equivalent on 1982-12-30. Applicant: Prothia USA, Inc..

Clearance details

Applicant: Prothia USA, Inc.
Product code: Code BXN
Advisory panel: Anesthesiology
Date received: 1982-12-06
Decision date: 1982-12-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Walker, MI, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code BXN

product code BXN

Other: 1
Total: 1

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.